Impact of the COVID-19 Pandemic on Cancer Researchers in 2020 : A Qualitative Study of Events to Inform Mitigation Strategies
Copyright © 2021 Fox, Beyer, Rammant, Morcom, Van Hemelrijck, Sullivan, Vanderpuye, Lombe, Tsunoda, Kutluk, Bhoo-Pathy, Pramesh, Yusuf, Booth, Shamieh, Siesling and Mukherji..
Introduction: The COVID-19 pandemic has had an unprecedented impact on global health systems and economies. With ongoing and future challenges posed to the field due to the pandemic, re-examining research priorities has emerged as a concern. As part of a wider project aiming to examine research priorities, here we aimed to qualitatively examine the documented impacts of the COVID-19 pandemic on cancer researchers. Materials and Methods: We conducted a literature review with the aim of identifying non-peer-reviewed journalistic sources and institutional blog posts which qualitatively documented the effects of the COVID-19 pandemic on cancer researchers. We searched on 12th January 2021 using the LexisNexis database and Google, using terms and filters to identify English-language media reports and blogs, containing references to both COVID-19 and cancer research. The targeted search returned 751 results, of which 215 articles met the inclusion criteria. These 215 articles were subjected to a conventional qualitative content analysis, to document the impacts of the pandemic on the field of cancer research. Results: Our analysis yielded a high plurality of qualitatively documented impacts, from which seven categories of direct impacts emerged: (1) COVID measures halting cancer research activity entirely; (2) COVID measures limiting cancer research activity; (3) forced adaptation of research protocols; (4) impacts on cancer diagnosis, cases, and services; (5) availability of resources for cancer research; (6) disruption to the private sector; and (7) disruption to supply chains. Three categories of consequences from these impacts also emerged: (1) potential changes to future research practice; (2) delays to the progression of the field; and (3) potential new areas of research interest. Discussion: The COVID-19 pandemic had extensive practical and economic effects on the field of cancer research in 2020 that were highly plural in nature. Appraisal of cancer research strategies in a post-COVID world should acknowledge the potential for substantial limitations (such as on financial resources, limited access to patients for research, decreased patient access to cancer care, staffing issues, administrative delays, or supply chain issues), exacerbated cancer disparities, advances in digital health, and new areas of research related to the intersection of cancer and COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Frontiers in public health - 9(2021) vom: 28., Seite 741223 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fox, Louis [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 05.01.2022 Date Revised 05.01.2022 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.3389/fpubh.2021.741223 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335025242 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335025242 | ||
| 003 | DE-627 | ||
| 005 | 20231225224933.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fpubh.2021.741223 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1116.xml |
| 035 | |a (DE-627)NLM335025242 | ||
| 035 | |a (NLM)34966713 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fox, Louis |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of the COVID-19 Pandemic on Cancer Researchers in 2020 |b A Qualitative Study of Events to Inform Mitigation Strategies |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2022 | ||
| 500 | |a Date Revised 05.01.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Fox, Beyer, Rammant, Morcom, Van Hemelrijck, Sullivan, Vanderpuye, Lombe, Tsunoda, Kutluk, Bhoo-Pathy, Pramesh, Yusuf, Booth, Shamieh, Siesling and Mukherji. | ||
| 520 | |a Introduction: The COVID-19 pandemic has had an unprecedented impact on global health systems and economies. With ongoing and future challenges posed to the field due to the pandemic, re-examining research priorities has emerged as a concern. As part of a wider project aiming to examine research priorities, here we aimed to qualitatively examine the documented impacts of the COVID-19 pandemic on cancer researchers. Materials and Methods: We conducted a literature review with the aim of identifying non-peer-reviewed journalistic sources and institutional blog posts which qualitatively documented the effects of the COVID-19 pandemic on cancer researchers. We searched on 12th January 2021 using the LexisNexis database and Google, using terms and filters to identify English-language media reports and blogs, containing references to both COVID-19 and cancer research. The targeted search returned 751 results, of which 215 articles met the inclusion criteria. These 215 articles were subjected to a conventional qualitative content analysis, to document the impacts of the pandemic on the field of cancer research. Results: Our analysis yielded a high plurality of qualitatively documented impacts, from which seven categories of direct impacts emerged: (1) COVID measures halting cancer research activity entirely; (2) COVID measures limiting cancer research activity; (3) forced adaptation of research protocols; (4) impacts on cancer diagnosis, cases, and services; (5) availability of resources for cancer research; (6) disruption to the private sector; and (7) disruption to supply chains. Three categories of consequences from these impacts also emerged: (1) potential changes to future research practice; (2) delays to the progression of the field; and (3) potential new areas of research interest. Discussion: The COVID-19 pandemic had extensive practical and economic effects on the field of cancer research in 2020 that were highly plural in nature. Appraisal of cancer research strategies in a post-COVID world should acknowledge the potential for substantial limitations (such as on financial resources, limited access to patients for research, decreased patient access to cancer care, staffing issues, administrative delays, or supply chain issues), exacerbated cancer disparities, advances in digital health, and new areas of research related to the intersection of cancer and COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a epidemic | |
| 650 | 4 | |a funding | |
| 650 | 4 | |a impact | |
| 650 | 4 | |a mitigation | |
| 650 | 4 | |a oncology | |
| 650 | 4 | |a pandemic | |
| 700 | 1 | |a Beyer, Katharina |e verfasserin |4 aut | |
| 700 | 1 | |a Rammant, Elke |e verfasserin |4 aut | |
| 700 | 1 | |a Morcom, Esme |e verfasserin |4 aut | |
| 700 | 1 | |a Van Hemelrijck, Mieke |e verfasserin |4 aut | |
| 700 | 1 | |a Sullivan, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Vanderpuye, Verna |e verfasserin |4 aut | |
| 700 | 1 | |a Lombe, Dorothy |e verfasserin |4 aut | |
| 700 | 1 | |a Tsunoda, Audrey Tieko |e verfasserin |4 aut | |
| 700 | 1 | |a Kutluk, Tezer |e verfasserin |4 aut | |
| 700 | 1 | |a Bhoo-Pathy, Nirmala |e verfasserin |4 aut | |
| 700 | 1 | |a Pramesh, Shanmugham C |e verfasserin |4 aut | |
| 700 | 1 | |a Yusuf, Aasim |e verfasserin |4 aut | |
| 700 | 1 | |a Booth, Christopher M |e verfasserin |4 aut | |
| 700 | 1 | |a Shamieh, Omar |e verfasserin |4 aut | |
| 700 | 1 | |a Siesling, Sabine |e verfasserin |4 aut | |
| 700 | 1 | |a Mukherji, Deborah |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in public health |d 2013 |g 9(2021) vom: 28., Seite 741223 |w (DE-627)NLM23377548X |x 2296-2565 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g day:28 |g pages:741223 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fpubh.2021.741223 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |b 28 |h 741223 | ||